To bring equity and resilience to the heart of vaccine innovation, access and epidemic preparedness, researchers and developers from the Global South propose transforming the way we organize and finance the development and manufacturing of countermeasures.

Moderated by Dr. Els Torreele, Independent researcher and consultant and Visiting Policy Fellow at the UCL institute for Innovation and Public Purpose, this webinar showcases the ongoing research successes and challenges for scientists making inroads into vaccine research and development today.

Opening address by the Rt. Hon. Helen Clark

Invited Panelists are:

Dr Amadou Sall, CEO, Institut Pasteur de Dakar, Senegal

Prof. Kiat Ruxrungtham, Co-Director, Chula Vaccine Research Center and Director, School of Global Health, Chulalongkorn University, Thailand

Prof. Petro Terblanche, CEO, Afrigen Biologics, Cape Town, South Africa – the Centre of the WHO/MPP mRNA technology development and transfer programme.

Carolina Gomez, Senior Advisor to the Secretary of Health of the City of Bogotá, Colombia